Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SX600 transforaminal epidural injection for lumbar radiculopathy
ACTRN12619001235190Phase 2Completed
- Sponsor
- SpineThera
- Start
- Nov 2019
- Modality
- Small Molecules, Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexamethasone acetate extended-release microspheres in lumbosacral radiculopathy, sponsored by SpineThera. Primary endpoint: 50% leg pain responder rate by Day 60. Started Nov 2019; status: completed.
02
Drugs
dexamethasone acetate extended-release microspheres
03
Conditions
lumbosacral radiculopathy
Beyond the preview
Go deeper on ACTRN12619001235190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001235190.